Atlantic Securities Analysts Give Pfizer Inc. (PFE) a $39.00 Price Target


The firm presently has a a "buy" rating on the biopharmaceutical company's stock. Atlantic Securities' target price points to a potential upside of 18.79% from the stock's current price.



from Biotech News